You are here » Home » Companies » Company Overview » Caplin Point Laboratories Ltd

Caplin Point Laboratories Ltd.

BSE: 524742 Sector: Health care
NSE: CAPLIPOINT ISIN Code: INE475E01026
BSE LIVE 15:43 | 21 Jul 709.85 18.80
(2.72%)
OPEN

692.15

HIGH

718.30

LOW

684.00

NSE 15:59 | 21 Jul 711.85 21.50
(3.11%)
OPEN

695.50

HIGH

718.80

LOW

684.00

OPEN 692.15
PREVIOUS CLOSE 691.05
VOLUME 24656
52-Week high 775.00
52-Week low 215.85
P/E 75.68
Mkt Cap.(Rs cr) 5,366
Buy Price 709.85
Buy Qty 135.00
Sell Price 0.00
Sell Qty 0.00
OPEN 692.15
CLOSE 691.05
VOLUME 24656
52-Week high 775.00
52-Week low 215.85
P/E 75.68
Mkt Cap.(Rs cr) 5,366
Buy Price 709.85
Buy Qty 135.00
Sell Price 0.00
Sell Qty 0.00

Caplin Point Laboratories Ltd. (CAPLIPOINT) - Company History

Incorporated in Apr.'90, Caplin Point Laboratories was promoted by P C Partheeban, T Palanisamy, S Karunakaran, S Jayaraman and B A Ahmed. The company manufactures pharmaceutical formulations in the form of tablets, ointments and capsules, liquid orals and oral powders. The company came out with a public issue in Nov.'94 and expanded its production capacity by setting up a new unit to manufacture its range of products, at Pondicherry. The company has retained its SSI status even after the expansion and thus will be out of the purview of the DPCO. During 1993-94, Triwin (a partnership firm) was merged with Caplin Point. The company entered into a technical agreement with American Remedies, US, and Concord Laboratories, US, for specific products, with a 30% buyback arrangement. It also imports bio-technological products to market them in India. The company has established a trading branch in Nairobi, Kenya, to sell its products in East Africa. It has also established a warehouse in Miami, US, by entering into a marketing tie-up with Lockett Medical Corporation, US.